Nerve Involvement in Indian Post Kala-Azar Dermal Leishmaniasis
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Vectorborne Transmission of Leishmania Infantum from Hounds, United States
Vectorborne Transmission of Leishmania infantum from Hounds, United States Robert G. Schaut, Maricela Robles-Murguia, and Missouri (total range 21 states) (12). During 2010–2013, Rachel Juelsgaard, Kevin J. Esch, we assessed whether L. infantum circulating among hunting Lyric C. Bartholomay, Marcelo Ramalho-Ortigao, dogs in the United States can fully develop within sandflies Christine A. Petersen and be transmitted to a susceptible vertebrate host. Leishmaniasis is a zoonotic disease caused by predomi- The Study nantly vectorborne Leishmania spp. In the United States, A total of 300 laboratory-reared female Lu. longipalpis canine visceral leishmaniasis is common among hounds, sandflies were allowed to feed on 2 hounds naturally in- and L. infantum vertical transmission among hounds has been confirmed. We found thatL. infantum from hounds re- fected with L. infantum, strain MCAN/US/2001/FOXY- mains infective in sandflies, underscoring the risk for human MO1 or a closely related strain. During 2007–2011, the exposure by vectorborne transmission. hounds had been tested for infection with Leishmania spp. by ELISA, PCR, and Dual Path Platform Test (Chembio Diagnostic Systems, Inc. Medford, NY, USA (Table 1). L. eishmaniasis is endemic to 98 countries (1). Canids are infantum development in these sandflies was assessed by Lthe reservoir for zoonotic human visceral leishmani- dissecting flies starting at 72 hours after feeding and every asis (VL) (2), and canine VL was detected in the United other day thereafter. Migration and attachment of parasites States in 1980 (3). Subsequent investigation demonstrated to the stomodeal valve of the sandfly and formation of a that many US hounds were infected with Leishmania infan- gel-like plug were evident at 10 days after feeding (Figure tum (4). -
Regulatory Mechanisms of Leishmania Aquaglyceroporin AQP1 Mansi Sharma Florida International University, [email protected]
Florida International University FIU Digital Commons FIU Electronic Theses and Dissertations University Graduate School 11-6-2015 Regulatory mechanisms of Leishmania Aquaglyceroporin AQP1 Mansi Sharma Florida International University, [email protected] DOI: 10.25148/etd.FIDC000197 Follow this and additional works at: https://digitalcommons.fiu.edu/etd Part of the Parasitology Commons Recommended Citation Sharma, Mansi, "Regulatory mechanisms of Leishmania Aquaglyceroporin AQP1" (2015). FIU Electronic Theses and Dissertations. 2300. https://digitalcommons.fiu.edu/etd/2300 This work is brought to you for free and open access by the University Graduate School at FIU Digital Commons. It has been accepted for inclusion in FIU Electronic Theses and Dissertations by an authorized administrator of FIU Digital Commons. For more information, please contact [email protected]. FLORIDA INTERNATIONAL UNIVERSITY Miami, Florida REGULATORY MECHANISMS OF LEISHMANIA AQUAGLYCEROPORIN AQP1 A dissertation submitted in partial fulfillment of the requirements for the degree of DOCTOR OF PHILOSOPHY in BIOLOGY by Mansi Sharma 2015 To: Dean Michael R. Heithaus College of Arts and Sciences This dissertation, written by Mansi Sharma, and entitled, Regulatory Mechanisms of Leishmania Aquaglyceroporin AQP1, having been approved in respect to style and intellectual content, is referred to you for judgment. We have read this dissertation and recommend that it be approved. _______________________________________ Lidia Kos _____________________________________ Kathleen -
Leishmaniasis Gap Analysis Report and Action Plan
30 December 2015 Leishmaniasis Gap Analysis Report and Action Plan Strengthening the Epidemiologial Surveillance, Diagnosis and Treatment of Visceral and Cutaneous Leishmaniasis in Albania, Jordan and Pakistan Connecting Organisations for Regional Disease Key Contributors: Surveillance (CORDS) Immeuble le Bonnel 20, Rue de la Villette 69328 LYON Dr Syed M. Mursalin EDEX 03, FRANCE Dr Sami Adel Sheikh Ali Tel. +33 (0)4 26 68 50 14 Email: [email protected] Dr James Crilly SIRET No 78948176900014 Dr Silvia Bino Published 30 December 2015 Editor: Ashley M. Bersani MPH, CPH List of Acronyms ACL Anthroponotic Cutaneous Leishmaniasis AIDS Acquired Immunodeficiency Syndrome CanL Canine Leishmaniasis CL Cutaneous Leishmaniasis CORDS Connecting Organisations for Regional Disease Surveillance DALY Disability-Adjusted Life Year DNDi Drugs for Neglected Diseases initiative IMC International Medical Corps IRC International Rescue Committee LHW Lady Health Worker MECIDS Middle East Consortium on Infectious Disease Surveillance ML Mucocutaneous Leishmaniasis MoA Ministry of Agriculture MoE Ministry of Education MoH Ministry of Health MoT Ministry of Tourism MSF Médecins Sans Frontières/Doctors Without Borders ND Neglected Disease NGO Non-governmental Organisation NTD Neglected Tropical Disease PCR Polymerase Chain Reaction PKDL Post Kala-Azar Dermal Leishmaniasis POHA Pak (Pakistan) One Health Alliance PZDD Parasitic and Zoonotic Diseases Department RDT Rapid Diagnostic Test SECID Southeast European Centre for Surveillance and Control of Infectious -
Leishmaniasis in the United States: Emerging Issues in a Region of Low Endemicity
microorganisms Review Leishmaniasis in the United States: Emerging Issues in a Region of Low Endemicity John M. Curtin 1,2,* and Naomi E. Aronson 2 1 Infectious Diseases Service, Walter Reed National Military Medical Center, Bethesda, MD 20814, USA 2 Infectious Diseases Division, Uniformed Services University, Bethesda, MD 20814, USA; [email protected] * Correspondence: [email protected]; Tel.: +1-011-301-295-6400 Abstract: Leishmaniasis, a chronic and persistent intracellular protozoal infection caused by many different species within the genus Leishmania, is an unfamiliar disease to most North American providers. Clinical presentations may include asymptomatic and symptomatic visceral leishmaniasis (so-called Kala-azar), as well as cutaneous or mucosal disease. Although cutaneous leishmaniasis (caused by Leishmania mexicana in the United States) is endemic in some southwest states, other causes for concern include reactivation of imported visceral leishmaniasis remotely in time from the initial infection, and the possible long-term complications of chronic inflammation from asymptomatic infection. Climate change, the identification of competent vectors and reservoirs, a highly mobile populace, significant population groups with proven exposure history, HIV, and widespread use of immunosuppressive medications and organ transplant all create the potential for increased frequency of leishmaniasis in the U.S. Together, these factors could contribute to leishmaniasis emerging as a health threat in the U.S., including the possibility of sustained autochthonous spread of newly introduced visceral disease. We summarize recent data examining the epidemiology and major risk factors for acquisition of cutaneous and visceral leishmaniasis, with a special focus on Citation: Curtin, J.M.; Aronson, N.E. -
Drugs for Amebiais, Giardiasis, Trichomoniasis & Leishmaniasis
Antiprotozoal drugs Drugs for amebiasis, giardiasis, trichomoniasis & leishmaniasis Edited by: H. Mirkhani, Pharm D, Ph D Dept. Pharmacology Shiraz University of Medical Sciences Contents Amebiasis, giardiasis and trichomoniasis ........................................................................................................... 2 Metronidazole ..................................................................................................................................................... 2 Iodoquinol ........................................................................................................................................................... 2 Paromomycin ...................................................................................................................................................... 3 Mechanism of Action ...................................................................................................................................... 3 Antimicrobial effects; therapeutics uses ......................................................................................................... 3 Leishmaniasis ...................................................................................................................................................... 4 Antimonial agents ............................................................................................................................................... 5 Mechanism of action and drug resistance ...................................................................................................... -
Identification of Leishmania Donovani Inhibitors from Pathogen Box Compounds of Medicine for Malaria Venture
bioRxiv preprint doi: https://doi.org/10.1101/716134; this version posted July 26, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. Identification of Leishmania donovani inhibitors from pathogen box compounds of Medicine for Malaria Venture Markos Tadele1¶, Solomon M. Abay2¶*, Eyasu Makonnen2,4, Asrat Hailu3 1 Ethiopian institute of agricultural research, Animal health research program, Holetta, Ethiopia 2Department of Pharmacology and clinical pharmacy, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia 3Department of Microbiology, Immunology and Parasitology, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia 4Center for Innovative Drug Development and Therapeutic Trials for Africa (CDT Africa), College of Health Sciences, Addis Ababa University * Corresponding author Email: [email protected], [email protected] ¶ These authors contributed equally to this work. Author Contributions Conceptualization and design the experiment: MT, SMA, EM, AH Investigation: MT, SMA, AH Data analysis: MT, SMA Funding acquisition and reagents contribution: SMA, AH Supervision: SMA, EM, AH Writing – original draft: MT Writing – review & editing: MT, SMA, EM, AH 1 | P a g e bioRxiv preprint doi: https://doi.org/10.1101/716134; this version posted July 26, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. -
Mucosal Leishmaniasis with Primary Oral Involvement: a Case Series and a Review of the Literature
Oral Diseases (2014) doi:10.1111/odi.12268 © 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd All rights reserved www.wiley.com REVIEW ARTICLE Mucosal leishmaniasis with primary oral involvement: a case series and a review of the literature MD Mignogna1, A Celentano1, S Leuci1, M Cascone1, D Adamo1, E Ruoppo1, G Favia2 1Department of Neurosciences, Reproductive and Odontostomatological Sciences, University Federico II of Naples, Naples; 2Head Oral Surgery Unit, Interdisciplinary Department of Medicine, University of Bari, Bari, Italy OBJECTIVE: To analyze retrospectively a case series of Introduction primary oral leishmaniasis and to review the literature on head–neck primary mucosal leishmaniasis (ML) in Leishmaniasis is a parasitic disease caused by several pro- immunocompetent patients. tozoan species of the genus Leishmania, belonging to the SUBJECTS AND METHODS: A PUBMED search was family Trypanosomatidae. After malaria and African try- ‘ ’ carried out from 1950 to 2013. Clinical records of panosomiasis ( sleeping sickness ), the leishmaniases are patients with primary head–neck mucosal manifesta- the third most important group of vectorborne diseases tions of leishmaniasis were analyzed. In addition, clinical and are ranked ninth in terms of the global burden of dis- records between 2001 and 2012 of patients with pri- ease of all infectious and parasitic diseases (Prabhu et al, mary oral manifestations were collected in two indepen- 1992; Stockdale and Newton, 2013). dent hospitals. The leishmaniases are widely dispersed, with transmis- fi RESULTS: Our multicenter case series revealed seven sion to humans on ve continents, and are endemic in 98 patients with oral leishmaniasis. The most commonly countries. -
Semi-Quantitative, Duplexed Qpcr Assay for the Detection of Leishmania Spp
Tropical Medicine and Infectious Disease Article Semi-Quantitative, Duplexed qPCR Assay for the Detection of Leishmania spp. Using Bisulphite Conversion Technology Ineka Gow 1,2,*, Douglas Millar 2 , John Ellis 1 , John Melki 2 and Damien Stark 3 1 School of Life Sciences, University of Technology, Sydney, NSW 2007, Australia; [email protected] 2 Genetic Signatures Ltd., Sydney, NSW 2042, Australia; [email protected] (D.M.); [email protected] (J.M.) 3 Microbiology Department, St. Vincent’s Hospital, Sydney, NSW 2010, Australia; [email protected] * Correspondence: [email protected]; +61-466263511 Received: 6 October 2019; Accepted: 28 October 2019; Published: 1 November 2019 Abstract: Leishmaniasis is caused by the flagellated protozoan Leishmania, and is a neglected tropical disease (NTD), as defined by the World Health Organisation (WHO). Bisulphite conversion technology converts all genomic material to a simplified form during the lysis step of the nucleic acid extraction process, and increases the efficiency of multiplex quantitative polymerase chain reaction (qPCR) reactions. Through utilization of qPCR real-time probes, in conjunction with bisulphite conversion, a new duplex assay targeting the 18S rDNA gene region was designed to detect all Leishmania species. The assay was validated against previously extracted DNA, from seven quantitated DNA and cell standards for pan-Leishmania analytical sensitivity data, and 67 cutaneous clinical samples for cutaneous clinical sensitivity data. Specificity was evaluated by testing 76 negative clinical samples and 43 bacterial, viral, protozoan and fungal species. The assay was also trialed in a side-by-side experiment against a conventional PCR (cPCR), based on the Internal transcribed spacer region 1 (ITS1 region). -
Louisiana Morbidity Report
Louisiana Morbidity Report Office of Public Health - Infectious Disease Epidemiology Section P.O. Box 60630, New Orleans, LA 70160 - Phone: (504) 568-8313 www.dhh.louisiana.gov/LMR Infectious Disease Epidemiology Main Webpage BOBBY JINDAL KATHY KLIEBERT GOVERNOR www.infectiousdisease.dhh.louisiana.gov SECRETARY September - October, 2015 Volume 26, Number 5 Cutaneous Leishmaniasis - An Emerging Imported Infection Louisiana, 2015 Benjamin Munley, MPH; Angie Orellana, MPH; Christine Scott-Waldron, MSPH In the summer of 2015, a total of 3 cases of cutaneous leish- and the species was found to be L. panamensis, one of the 4 main maniasis, all male, were reported to the Department of Health species associated with progression to metastasized mucosal and Hospitals’ (DHH) Louisiana Office of Public Health (OPH). leishmaniasis in some instances. The first 2 cases to be reported were newly acquired, a 17-year- The third case to be reported in the summer of 2015 was from old male and his father, a 49-year-old male. Both had traveled to an Australian resident with an extensive travel history prior to Costa Rica approximately 2 months prior to their initial medical developing the skin lesion, although exact travel history could not consultation, and although they noticed bug bites after the trip, be confirmed. The case presented with a non-healing skin ulcer they did not notice any flies while traveling. It is not known less than 1 cm in diameter on his right leg. The ulcer had been where transmission of the parasite occurred while in Costa Rica, present for 18 months and had not previously been treated. -
ESCMID Online Lecture Library © by Author
Microscopy and PCR for diagnosis of parasitic infections: a tale of two amazing powerful techniques Tom van Gool MD, PhD, Aldert Bart PhD Section Clinical Parasitology, Department Medical Microbiology, Academic Medical Center, Amsterdam, ESCMID OnlineNetherlands Lecture Library © by author Academic Medical Center (AMC), Amsterdam, Netherlands Patients from routine clinical care large university hospital, Dept. ESCMIDTropical Medicine Online and general practitioners Lecture from surroundings. Library © by author Microscopy: an old, but still extremely useful diagnostic tool in clinical parasitology! Needed: 1: a microscope 2: a well trained technician 3: saline, iodine, or other (cheap) stain…. and… a wealth of information becomes available! ESCMID Online Lecture Library © by author Molecular Diagnosis Acanthamoeba detection and typing Parasitic Infections, Angiostrongylus detection (AMC, NL) Babesia detection and typing Blastocystis detection and typing Cryptosporidium detection Dientamoeba fragilis detection Entamoeba detection and typing Echinococcus detection and typing ….a large variety of Giardia detection and typing protozoa and helminths.... Leishmania detection and typing Malaria detection and typing Microsporidium detection and typing Opisthorchis detection and typing Schistosoma spp detection and typing Toxocara detection TrypanosomaESCMID cruzi detection Online and typing Lecture Library Intestinal helminths i.e. strongyloides © by author Current priorities in diagnostic approaches - Malaria - Leishmania - Intestinal parasites -
Manual for the Diagnosis and Treatment of Leishmaniasis
Republic of the Sudan Federal Ministry of Health Communicable and Non-Communicable Diseases Control Directorate MANUAL FOR THE DIAGNOSIS AND TREATMENT OF LEISHMANIASIS November 2017 Acknowledgements The Communicable and Non-Communicable Diseases Control Directorate (CNCDCD), Federal Ministry of Health, Sudan, would like to acknowledge all the efforts spent on studying, controlling and reducing morbidity and mortality of leishmaniasis in Sudan, which culminated in the formulation of this manual in April 2004, updated in October 2014 and again in November 2017. We would like to express our thanks to all National institutions, organizations, research groups and individuals for their support, and the international organization with special thanks to WHO, MSF and UK- DFID (KalaCORE). I Preface Leishmaniasis is a major health problem in Sudan. Visceral, cutaneous and mucosal forms of leishmaniasis are endemic in various parts of the country, with serious outbreaks occurring periodically. Sudanese scientists have published many papers on the epidemiology, clinical manifestations, diagnosis and management of these complex diseases. This has resulted in a better understanding of the pathogenesis of the various forms of leishmaniasis and has led to more accurate and specific diagnostic methods and better therapy. Unfortunately, many practitioners are unaware of these developments and still rely on outdated diagnostic procedures and therapy. This document is intended to help those engaged in the diagnosis, treatment and nutrition of patients with various forms of leishmaniasis. The guidelines are based on publications and experience of Sudanese researchers and are therefore evidence based. The guidelines were agreed upon by top researchers and clinicians in workshops organized by the Leishmaniasis Control response at the Communicable and Non-Communicable Diseases Control Directorate, Federal Ministry of Health, Sudan. -
Catalogue of Protozoan Parasites Recorded in Australia Peter J. O
1 CATALOGUE OF PROTOZOAN PARASITES RECORDED IN AUSTRALIA PETER J. O’DONOGHUE & ROBERT D. ADLARD O’Donoghue, P.J. & Adlard, R.D. 2000 02 29: Catalogue of protozoan parasites recorded in Australia. Memoirs of the Queensland Museum 45(1):1-164. Brisbane. ISSN 0079-8835. Published reports of protozoan species from Australian animals have been compiled into a host- parasite checklist, a parasite-host checklist and a cross-referenced bibliography. Protozoa listed include parasites, commensals and symbionts but free-living species have been excluded. Over 590 protozoan species are listed including amoebae, flagellates, ciliates and ‘sporozoa’ (the latter comprising apicomplexans, microsporans, myxozoans, haplosporidians and paramyxeans). Organisms are recorded in association with some 520 hosts including mammals, marsupials, birds, reptiles, amphibians, fish and invertebrates. Information has been abstracted from over 1,270 scientific publications predating 1999 and all records include taxonomic authorities, synonyms, common names, sites of infection within hosts and geographic locations. Protozoa, parasite checklist, host checklist, bibliography, Australia. Peter J. O’Donoghue, Department of Microbiology and Parasitology, The University of Queensland, St Lucia 4072, Australia; Robert D. Adlard, Protozoa Section, Queensland Museum, PO Box 3300, South Brisbane 4101, Australia; 31 January 2000. CONTENTS the literature for reports relevant to contemporary studies. Such problems could be avoided if all previous HOST-PARASITE CHECKLIST 5 records were consolidated into a single database. Most Mammals 5 researchers currently avail themselves of various Reptiles 21 electronic database and abstracting services but none Amphibians 26 include literature published earlier than 1985 and not all Birds 34 journal titles are covered in their databases. Fish 44 Invertebrates 54 Several catalogues of parasites in Australian PARASITE-HOST CHECKLIST 63 hosts have previously been published.